Holen Sie sich die Stockscreener-App
66.97
1.30%
-0.88
Handel nachbörslich:
66.95
-0.02
-0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$67.85
Offen:
$67.73
24-Stunden-Volumen:
5.91M
Relative Volume:
0.59
Marktkapitalisierung:
$85.34B
Einnahmen:
$378.96B
Nettoeinkommen (Verlust:
$5.28B
KGV:
15.98
EPS:
4.19
Netto-Cashflow:
$5.94B
1W Leistung:
-0.73%
1M Leistung:
-4.57%
6M Leistung:
+20.58%
1J Leistung:
+20.28%
1-Tages-Spanne:
$66.81
$67.76
1-Wochen-Bereich:
$65.84
$68.52
52-Wochen-Spanne:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced (NYSE:CVS) - Seeking Alpha
Is CVS Health Corporation (CVS) the Best Performing Healthcare Stock to Buy Now? - Insider Monkey
AG claims CVS denied discounts to MassHealth members - Gloucester Daily Times
CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal (NYSE:CVS) - Seeking Alpha
CVS Health (NYSE:CVS) Price Target Raised to $81.00 at Royal Bank of Canada - MarketBeat
CVS rips a page out of bankrupt drugstore chain's playbook - TheStreet
Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy - Bloomberg.com
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025 - MSN
Collar Capital Management LLC Makes New $520,000 Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
AG alleges CVS didn’t share discounts with MassHealth members - The Boston Globe
AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries - Stock Titan
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
FY2025 EPS Forecast for CVS Health Increased by Analyst - MarketBeat
Cantor Fitzgerald maintains CVS Health stock at Overweight By Investing.com - Investing.com Nigeria
CVS Hid Prescription Discounts From Medicaid, States Allege - Law360
AG Campbell sues CVS for allegedly overcharging MassHealth for prescriptions - WWLP
JPMorgan raises CVS Health stock target to $86, keeps Overweight rating - Investing.com
CVS Can Arbitrate Clinic Worker's Suit Alleging Illegal Layoffs - Law360
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
Jim Cramer on CVS Health Corporation (CVS): ‘David Joyner’s Stunning Turnaround Continues’ - Insider Monkey
Glenview Capital Reduces Stake in CVS (CVS) Post Strong Earnings - GuruFocus
Cantor Fitzgerald Boosts Earnings Estimates for CVS Health - Defense World
Leerink Partnrs Has Weak Estimate for CVS Health Q2 Earnings - MarketBeat
Becker Capital Management Inc. Lowers Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Activist Glenview cuts stake in CVS after strong first-quarter earnings - Reuters
Activist Glenview cuts stake in CVS after strong first-quarter earnings By Reuters - Investing.com
CVS Achieves 25% Return Amid Turnaround Efforts | CVS Stock News - GuruFocus
Activist investor Glenview Capital reduces stake in CVS Health - NewsBreak: Local News & Alerts
Activist Investor Glenview Capital Reduces Stake in CVS Health - US News Money
Glenviw issues statement on CVS Health - TipRanks
CVS’s ‘Healthy’ Results Prompts Activist Glenview to Pare Stake - Bloomberg
Glenview Capital Reveals How New CVS Leadership Delivered 25% Returns in Just 12 Months - Stock Titan
Cantor Fitzgerald maintains CVS Health stock at Overweight - Investing.com
CVS Health (CVS) Sees Price Target Upgrade by Wells Fargo | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Boosted by Wells Fargo Amid Perfor - GuruFocus
CVS Health’s SWOT analysis: stock poised for growth amid challenges - Investing.com
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Resu - GuruFocus
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challe - GuruFocus
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
One68 Global Capital LLC Buys Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
What is CVS? 'We are ... working through that very question' - Yahoo Finance
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
Northern Trust Corp Acquires 928,833 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
1.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):